The surge in options trading boosted revenue for the nation's two stock exchanges and attracted the biggest Wall Street firms ...
Its consolidated revenue grew 20% year-on-year (y-o-y), from ₹4,369 crore in Q2FY24 to ₹5,237 crore in Q2FY25. The firm ...
Suven Pharmaceuticals (SPL) advanced 3.67% to Rs 1,247.95 after the drug maker's consolidated net profit increased 3.34% to Rs 82.21 crore on 11.54% rise in revenue from operations to Rs 257.72 crore ...
This new platform aims to boost revenue options for Indian game developers, who often face low in-app purchase (IAP) ...